News
Next-generation vaccines against gastrointestinal mucosal pathogens: kick-off meeting in Munich
Munich, 18&19 September 2023 - The members of Vax2Muc consortium met in Munich for the first in-person meeting to discuss project activities over the coming five years.
Game-changing research collaboration starts: Vax2Muc will pave the way for next-generation vaccines against gastrointestinal mucosal pathogens
Munich, 25 August 2023 - The Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM) announced today the launch of Vax2Muc. Over the next 5 years, Vax2Muc will receive almost 8.5 million Euro from Horizon Europe to develop next generation vaccines against gastrointestinal mucosal pathogens.

